Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

256 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
A Retrospective Cohort Study of a Newly Proposed Criteria for Sporadic Creutzfeldt-Jakob Disease.
Nonaka T, Ae R, Kosami K, Tange H, Kaneko M, Nakagaki T, Hamaguchi T, Sanjo N, Nakamura Y, Kitamoto T, Kuroiwa Y, Kasuga K, Doyu M, Tanaka F, Abe K, Murayama S, Yabe I, Mochizuki H, Matsushita T, Murai H, Aoki M, Fujita K, Harada M, Takao M, Tsukamoto T, Iwasaki Y, Yamada M, Mizusawa H, Satoh K, Nishida N. Nonaka T, et al. Among authors: kasuga k. Diagnostics (Basel). 2024 Oct 30;14(21):2424. doi: 10.3390/diagnostics14212424. Diagnostics (Basel). 2024. PMID: 39518392 Free PMC article.
Prognostic Nutrition Index as a Biomarker for Treatment Sensitivity to Chemotherapy and Nivolumab as the First-Line Treatment in Patients with Unresectable Advanced or Recurrent Gastric Cancer: A Multicenter Study.
Nakazawa N, Sano A, Kumakura Y, Yamashita T, Tanaka N, Saito K, Kimura A, Kasuga K, Nakazato K, Yoshinari D, Shimizu H, Ubukata Y, Hosaka H, Shiraishi T, Sakai M, Sohda M, Shirabe K, Saeki H. Nakazawa N, et al. Among authors: kasuga k. Oncology. 2024 Oct 24:1-8. doi: 10.1159/000541544. Online ahead of print. Oncology. 2024. PMID: 39447553
Multicentre study to assess the performance of an artificial intelligence instrument to support qualitative diagnosis of colorectal polyps.
Sato K, Kuramochi M, Tsuchiya A, Yamaguchi A, Hosoda Y, Yamaguchi N, Nakamura N, Itoi Y, Hashimoto Y, Kasuga K, Tanaka H, Kuribayashi S, Takeuchi Y, Uraoka T. Sato K, et al. Among authors: kasuga k. BMJ Open Gastroenterol. 2024 Oct 22;11(1):e001553. doi: 10.1136/bmjgast-2024-001553. BMJ Open Gastroenterol. 2024. PMID: 39438054 Free PMC article.
Serum Derivatives-Reactive Oxygen Metabolite Levels as a Marker of Clinical Conditions in Patients with Bronchial Asthma, COPD, or Asthma-COPD Overlap: A Prospective Study.
Nakamoto K, Watanabe M, Saito M, Kasuga K, Miyaoka C, Yoshida Y, Kobayashi F, Nunokawa H, Aso J, Nakamoto Y, Ishida M, Sada M, Honda K, Takata S, Saraya T, Shimoda M, Tanaka Y, Saotome M, Ohta K, Ishii H. Nakamoto K, et al. Among authors: kasuga k. J Clin Med. 2024 Oct 9;13(19):6022. doi: 10.3390/jcm13196022. J Clin Med. 2024. PMID: 39408083 Free PMC article.
CSF proteomics identifies early changes in autosomal dominant Alzheimer's disease.
Shen Y, Timsina J, Heo G, Beric A, Ali M, Wang C, Yang C, Wang Y, Western D, Liu M, Gorijala P, Budde J, Do A, Liu H, Gordon B, Llibre-Guerra JJ, Joseph-Mathurin N, Perrin RJ, Maschi D, Wyss-Coray T, Pastor P, Renton AE, Surace EI, Johnson ECB, Levey AI, Alvarez I, Levin J, Ringman JM, Allegri RF, Seyfried N, Day GS, Wu Q, Fernández MV, Tarawneh R, McDade E, Morris JC, Bateman RJ, Goate A; Dominantly Inherited Alzheimer Network; Ibanez L, Sung YJ, Cruchaga C. Shen Y, et al. Cell. 2024 Oct 31;187(22):6309-6326.e15. doi: 10.1016/j.cell.2024.08.049. Epub 2024 Sep 26. Cell. 2024. PMID: 39332414 Free PMC article.
Identification of Biomarkers for Assessing Treatment Efficacy of Chemotherapy plus Nivolumab as the First Line in Patients with Unresectable Advanced or Recurrent Gastric Cancer: A Multicenter Study.
Nakazawa N, Sohda M, Hosoi N, Watanabe T, Kumakura Y, Yamashita T, Tanaka N, Saito K, Kimura A, Kasuga K, Nakazato K, Yoshinari D, Shimizu H, Ubukata Y, Hosaka H, Sano A, Sakai M, Ogawa H, Shirabe K, Saeki H. Nakazawa N, et al. Among authors: kasuga k. Oncology. 2024 Sep 12:1-8. doi: 10.1159/000540841. Online ahead of print. Oncology. 2024. PMID: 39265540
Conversion Surgery After Chemotherapy Plus Nivolumab as the First-Line Treatment for Unresectable Advanced or Recurrent Gastric Cancer and a Biomarker Study Using the Gustave Roussy Immune Score: A Multicenter Study.
Nakazawa N, Sohda M, Hosoi N, Watanabe T, Kumakura Y, Yamashita T, Tanaka N, Saito K, Kimura A, Kasuga K, Nakazato K, Yoshinari D, Shimizu H, Ubukata Y, Hosaka H, Sano A, Sakai M, Ogawa H, Shirabe K, Saeki H. Nakazawa N, et al. Among authors: kasuga k. Ann Surg Oncol. 2024 Dec;31(13):9023-9029. doi: 10.1245/s10434-024-16161-4. Epub 2024 Sep 3. Ann Surg Oncol. 2024. PMID: 39225857
256 results